Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Quantib B.V. — Predicate Candidate Screening

11 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

73 daysmedian FDA review time
159 days90th percentile
11clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K253682DeepHealth ProstateAIQuantib B.V.2026-04-291590
K251527Brain WMHQuantib B.V.2025-09-251290
K230772Quantib ProstateQuantib B.V.2023-04-17270
K221106Quantib ProstateQuantib B.V.2022-05-13280
K213737Quantib NDQuantib B.V.2022-01-14460
K202501Quantib ProstateQuantib B.V.2020-10-11410
K200899Quantib AI NodeQuantib B.V.2020-06-15730
K182564Quantib NDQuantib B.V.2018-12-271000
K173939Quantib BrainQuantib B.V.2018-03-09730
K163013Quantib Brain 1.2Quantib B.V.2017-01-06700
K153351Quantib Brain 1Quantib B.V.2016-06-172100

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda